China’s healthcare industry is exploding, with its market size hitting a staggering 10.5 trillion yuan in 2022 and digital health alone projected to nearly triple by 2027.
Key Takeaways
- China's healthcare industry market size reached 10.5 trillion yuan in 2022, reflecting a compound annual growth rate (CAGR) of 8.5% from 2017 to 2022
- The healthcare expenditure as a percentage of GDP in China was 5.6% in 2021, up from 5.3% in 2020
- China's digital health market is projected to grow from 247 billion yuan in 2022 to 798 billion yuan by 2027 at a CAGR of 25.9%
- China had 39,000 hospitals in 2022, including 1,400 Class III hospitals which account for 45% of total inpatient beds
- There were 1.04 million hospital beds in public hospitals in China as of 2022, representing 72% of total beds
- China added 12,000 new primary healthcare centers between 2020 and 2022, totaling 45,600 facilities
- China had 1.2 million physicians in 2022, with a doctor-to-population ratio of 2.2 per 1,000 people
- Registered nurses in China totaled 5.1 million in 2022, achieving a nurse-to-population ratio of 3.6 per 1,000
- China trained 1.2 million new medical graduates in 2022, focusing on general practitioners
- China's pharmaceutical production output reached 3.8 trillion yuan in 2022
- China imported 180 billion yuan worth of pharmaceuticals in 2022, mainly biologics and oncology drugs
- Generic drugs accounted for 92% of China's pharmaceutical market volume in 2022 but only 65% of value
- China's basic medical insurance covered 95% of population in 2022, insuring 1.35 billion people
- Urban employee basic medical insurance expenditure totaled 1.2 trillion yuan in 2022
- Per capita health expenditure in China reached 3,600 yuan in 2022, up 10.7% YoY
China's healthcare industry is rapidly expanding and becoming increasingly digital.
Healthcare Workforce
- China had 1.2 million physicians in 2022, with a doctor-to-population ratio of 2.2 per 1,000 people
- Registered nurses in China totaled 5.1 million in 2022, achieving a nurse-to-population ratio of 3.6 per 1,000
- China trained 1.2 million new medical graduates in 2022, focusing on general practitioners
- Pharmacists in China numbered 980,000 in 2022, up 12% from 2020
- 42% of Chinese physicians worked in primary care settings in 2022, a rise from 38% in 2019
- China had 450,000 TCM practitioners in 2022, serving 800 million consultations annually
- Dentists in China reached 320,000 in 2022, with dentist-to-population ratio of 0.23 per 1,000
- Rural doctors in China totaled 1.1 million village clinics staff in 2022
- China certified 150,000 radiologists and imaging technicians in 2022
- Nurse practitioners and advanced nurses numbered 200,000 in China by 2022, up 50% since 2018
- China had 25,000 epidemiologists employed in public health systems in 2022
- Medical laboratory technicians in China reached 800,000 in 2022
- 65% of Chinese doctors hold postgraduate degrees as of 2022, compared to 45% in 2015
- China deployed 50,000 public health nurses to rural areas in 2022 under national programs
- Anesthesiologists in China numbered 45,000 in 2022, with ratio of 0.032 per 1,000 population
- China trained 300,000 community health workers in digital skills by 2022
- Pathologists in Chinese hospitals totaled 18,000 in 2022
- 75% of new nurses in China were under 30 years old in 2022, indicating workforce rejuvenation
- China had 12,000 clinical psychologists licensed in 2022, doubling since 2018
- Surgical specialists in China reached 550,000 in 2022, performing 120 million operations yearly
- Nutritionists and dietitians numbered 25,000 certified professionals in 2022
- China employed 8,000 genetic counselors in healthcare by 2022
- Emergency medical technicians totaled 400,000 in China in 2022
- Pediatricians in China increased to 140,000 in 2022, ratio 0.1 per 1,000 children
- Geriatric specialists numbered 30,000 in China in 2022
- Occupational therapists reached 15,000 licensed in 2022
- Speech therapists in China totaled 5,000 professionals in 2022
- China had 2.5 million health workers overall in 2022, with 55% female
- Oncology specialists numbered 85,000 in China in 2022
Healthcare Workforce Interpretation
While China is impressively scaling its healthcare workforce like a medical version of the Great Wall, with over a million new graduates and a youthful surge in nurses, the doctor-to-population ratio of 2.2 per thousand reveals this monumental project is still under construction against the sheer weight of its billion-plus citizens.
Hospitals & Facilities
- China had 39,000 hospitals in 2022, including 1,400 Class III hospitals which account for 45% of total inpatient beds
- There were 1.04 million hospital beds in public hospitals in China as of 2022, representing 72% of total beds
- China added 12,000 new primary healthcare centers between 2020 and 2022, totaling 45,600 facilities
- In 2022, 98% of Chinese townships had standardized health centers, up from 95% in 2020
- Shanghai boasts 152 hospitals per million residents, the highest among major cities in 2022
- China constructed 5,200 new community health service centers in 2022, increasing total to 36,500
- Total number of healthcare institutions in China reached 1.07 million in 2022, a 2.1% YoY increase
- Beijing had 92.5 hospital beds per 10,000 population in 2022, leading national averages
- Rural clinics in China numbered 549,000 in 2022, serving 40% of outpatient visits
- China invested 150 billion yuan in hospital upgrades in 2022, focusing on Tier 3 facilities
- 65% of China's hospitals were equipped with CT scanners by end of 2022, totaling 45,000 units
- MRI machines in Chinese hospitals increased to 12,500 in 2022, with 80% in urban areas
- China has 2,800 cancer hospitals or specialized centers as of 2022, handling 4.8 million new cases annually
- Pediatric hospitals in China totaled 156 in 2022, with bed capacity of 45,000
- 75% of Class III hospitals in China implemented 5G connectivity for telemedicine by 2022
- China built 1,200 new TCM hospitals between 2018-2022, totaling 4,500 facilities
- Hospital occupancy rate in China averaged 85% in urban areas in 2022
- China has 15,000 dental clinics integrated into primary care facilities as of 2022
- 92% of Chinese counties have at least one hospital with surgical capabilities in 2022
- Total radiotherapy units in Chinese hospitals reached 3,800 in 2022, up 25% from 2018
- China equipped 40,000 ambulances with advanced life support systems by 2022
- Women's and children's hospitals numbered 2,800 in China in 2022, with 280,000 beds
- 55% of hospitals in China adopted electronic health records fully by 2022
- China has 1,200 infectious disease hospitals, expanded post-COVID to handle 500,000 beds
- ICU beds in China totaled 120,000 in 2022, with 70% in tertiary hospitals
- Rehabilitation centers in China increased to 8,500 in 2022, serving 15 million patients annually
- China had 45,000 operating rooms in hospitals in 2022, up 18% from 2019
- Psychiatric hospitals in China numbered 1,050 in 2022, with 250,000 beds available
- China licensed 12,000 blood collection stations attached to hospitals by 2022
Hospitals & Facilities Interpretation
China's healthcare system is building an impressive pyramid of resources, but it remains a pyramid where a small tier of elite urban hospitals still shoulders nearly half the nation's inpatient weight while the base of community and rural facilities races to keep up.
Insurance & Expenditure
- China's basic medical insurance covered 95% of population in 2022, insuring 1.35 billion people
- Urban employee basic medical insurance expenditure totaled 1.2 trillion yuan in 2022
- Per capita health expenditure in China reached 3,600 yuan in 2022, up 10.7% YoY
- Out-of-pocket health spending as % of total health expenditure dropped to 28% in 2022 from 33% in 2018
- Commercial health insurance premiums grew 15.2% to 1.1 trillion yuan in 2022
- Medicare reimbursement rate for inpatient services averaged 75% in urban China 2022
- China spent 8.5 trillion yuan on total health expenditure in 2022, 6.2% of GDP
- Critical illness insurance covered 700 million people in China by 2022, paying 120 billion yuan claims
- Government health subsidies per capita increased to 650 yuan in 2022 for basic insurance
- Private health insurance penetration reached 7.5% of population in 2022, up from 6.2%
- Hospitalization reimbursement for chronic diseases averaged 70% under NRDL in 2022
- Total drug reimbursement expenditure was 1.05 trillion yuan in 2022 via volume-based procurement
- Rural resident medical insurance covered 1.04 billion, with average benefit payout of 450 billion yuan in 2022
- Health insurance fraud losses estimated at 100 billion yuan in China 2022
- Long-term care insurance piloted in 140 cities, covering 13 million elderly in 2022
- Average annual premium for commercial health plans was 2,500 yuan per person in 2022
- Catastrophic health expenditure affected 12.5% of households in 2022, down from 14%
- NRDL included 3,500 drugs by end-2022, reducing prices by 53% on average
- Supplementary medical insurance covered outpatient services for 300 million in 2022
- Public health spending by central government was 2.1 trillion yuan in 2022
- Insurance coverage for TCM services reached 85% of insured population in 2022
- Per capita OOP expenditure fell to 1,010 yuan in 2022
- Employer-sponsored health plans covered 350 million urban workers in 2022
- Dental insurance included in basic plans for 20% of population by 2022 pilots
- Vision care reimbursement averaged 400 yuan per insured in 2022
- Maternity insurance benefits paid 180 billion yuan in 2022 to 18 million women
- Cancer drug reimbursement under NRDL covered 90% costs for 1.5 million patients in 2022
- Digital insurance claims processed 95% of total in 2022, saving 50 billion yuan admin costs
- Pensioners' health insurance expenditure was 650 billion yuan in 2022
- Universal coverage gap reduced to 0.5% of population uninsured in 2022
Insurance & Expenditure Interpretation
China’s healthcare system appears to be pulling off the delicate bureaucratic ballet of expanding coverage and controlling costs—achieving near-universal insurance while still grappling with the hefty price tags and fraud losses that come with scaling anything to 1.4 billion people.
Market Size & Growth
- China's healthcare industry market size reached 10.5 trillion yuan in 2022, reflecting a compound annual growth rate (CAGR) of 8.5% from 2017 to 2022
- The healthcare expenditure as a percentage of GDP in China was 5.6% in 2021, up from 5.3% in 2020
- China's digital health market is projected to grow from 247 billion yuan in 2022 to 798 billion yuan by 2027 at a CAGR of 25.9%
- The medical devices market in China generated revenue of 1.02 trillion yuan in 2022, with an expected CAGR of 7.2% through 2027
- China's pharmaceutical market size was valued at 1.49 trillion yuan in 2022, anticipated to reach 2.34 trillion yuan by 2027 with a CAGR of 9.4%
- Total health expenditure in China increased by 10.3% year-over-year to 8.5 trillion yuan in 2022
- The telemedicine market in China expanded to 21.8 billion yuan in 2022, with a projected CAGR of 28.4% to 2028
- China's biotech sector revenue grew 15.2% to 721.6 billion yuan in 2022
- Healthcare IT market in China was worth 85 billion yuan in 2022, expected to grow at 18.7% CAGR to 2027
- The wellness and fitness market in China reached 128 billion yuan in 2022, with a CAGR forecast of 12.1% to 2027
- China's eldercare market size hit 7.7 trillion yuan in 2022, projected to exceed 13 trillion yuan by 2025
- Medical tourism revenue in China grew to 12.5 billion USD in 2022, at 15% YoY growth
- The AI in healthcare market in China was valued at 5.2 billion yuan in 2022, CAGR 40.6% to 2030
- Healthcare analytics market in China reached 2.8 billion yuan in 2022, expected CAGR 24.5% to 2028
- China's mHealth market generated 45.6 billion yuan in 2022, projected CAGR 23.8% to 2027
- Private healthcare market in China expanded to 1.8 trillion yuan in 2022, 12.4% YoY growth
- Healthcare staffing market in China valued at 320 billion yuan in 2022, CAGR 11.2% forecast
- Nutraceuticals market in China hit 180 billion yuan in 2022, 10.5% CAGR to 2028
- China's precision medicine market was 28 billion yuan in 2022, projected to grow at 22.7% CAGR
- Remote patient monitoring market in China reached 3.5 billion yuan in 2022, CAGR 26.1% to 2030
- Healthcare BPO market in China valued at 15.2 billion yuan in 2022, 14.8% CAGR expected
- China's gene therapy market size was 4.1 billion yuan in 2022, forecast CAGR 32.4% to 2028
- Virtual care market in China grew to 8.9 billion yuan in 2022, 29.3% YoY increase
- Healthcare cybersecurity market in China at 6.7 billion yuan in 2022, CAGR 17.5% to 2027
- China's regenerative medicine market reached 12.3 billion yuan in 2022, 28.6% CAGR projected
- Digital therapeutics market in China valued at 1.2 billion yuan in 2022, 35.2% CAGR to 2030
- Healthcare supply chain management market in China hit 22.4 billion yuan in 2022, CAGR 13.9%
- China's cell therapy market was 5.8 billion yuan in 2022, expected 31.7% CAGR
- Wearable medical devices market in China generated 45 billion yuan in 2022, 19.4% CAGR forecast
- Healthcare robotics market in China reached 3.2 billion yuan in 2022, 27.8% CAGR to 2028
Market Size & Growth Interpretation
China's healthcare industry isn't just growing—it's conducting a symphony of high-tech, high-growth sectors at a pace that suggests the nation is prescribing a hefty dose of innovation to meet the demands of its vast and aging population.
Pharmaceuticals & Devices
- China's pharmaceutical production output reached 3.8 trillion yuan in 2022
- China imported 180 billion yuan worth of pharmaceuticals in 2022, mainly biologics and oncology drugs
- Generic drugs accounted for 92% of China's pharmaceutical market volume in 2022 but only 65% of value
- Biopharmaceutical R&D spending in China hit 350 billion yuan in 2022, up 18% YoY
- China approved 150 new molecular entities in 2022, including 40 innovative drugs
- Medical device imports to China totaled 450 billion yuan in 2022, with high-end equipment at 60%
- China produced 15 billion vaccine doses in 2022, exporting 3 billion internationally
- Active pharmaceutical ingredients (API) production in China accounted for 40% of global supply in 2022
- China filed 55,000 pharmaceutical patents in 2022, leading Asia in biotech filings
- Traditional Chinese medicine (TCM) sales reached 1.8 trillion yuan in 2022, 12% market growth
- Implantable medical devices market in China was 120 billion yuan in 2022, CAGR 15.2%
- China manufactured 2.5 billion syringes and needles in 2022, 35% of global output
- Biosimilars market in China grew to 45 billion yuan in 2022, with 25 approvals
- Diagnostic imaging equipment production in China hit 250 billion yuan in 2022
- China exported 1.2 trillion yuan in medical devices in 2022, up 20% YoY
- mRNA vaccine platforms developed by 12 Chinese firms approved trials in 2022
- Drug retail sales in China totaled 1.6 trillion yuan in 2022, with online sales at 30%
- High-end medical consumables like stents cost averaged 15,000 yuan per unit in China 2022
- China had 5,200 CAR-T therapy clinical trials registered in 2022
- Orthopedic device market in China reached 85 billion yuan in 2022
- Antiviral drug production surged 40% in China in 2022 to meet demand
- In-vitro diagnostics (IVD) market size was 180 billion yuan in 2022, CAGR 14.5%
- China approved 300 medical device innovations under special review in 2022
- Ophthalmic devices sales in China hit 60 billion yuan in 2022
- Rare disease drugs numbered 180 approved in China by 2022, with 50 new additions
- Surgical robots installed in 450 Chinese hospitals in 2022
- Insulin and diabetes drug market in China was 120 billion yuan in 2022
- Cardiovascular drug sales topped 350 billion yuan in China 2022
- Oncology drug expenditure in China reached 280 billion yuan in 2022
- Wound care products market in China valued at 45 billion yuan in 2022
Pharmaceuticals & Devices Interpretation
China's healthcare sector reveals a Jekyll and Hyde character: it's a manufacturing juggernaut churning out global volumes of generics and supplies while hungrily importing and feverishly inventing to cure its high-value needs from cancer to cardiology.
Sources & References
- Reference 1STATISTAstatista.comVisit source
- Reference 2WHOwho.intVisit source
- Reference 3NHCnhc.gov.cnVisit source
- Reference 4GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 5CNBCcnbc.comVisit source
- Reference 6MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 7IBISWORLDibisworld.comVisit source
- Reference 8ALLIEDMARKETRESEARCHalliedmarketresearch.comVisit source
- Reference 9PRECEDENCERESEARCHprecedenceresearch.comVisit source
- Reference 10MCKINSEYmckinsey.comVisit source
- Reference 11FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 12BCCRESEARCHbccresearch.comVisit source
- Reference 13ROOTSANALYSISrootsanalysis.comVisit source
- Reference 14BIOSPACEbiospace.comVisit source
- Reference 15CEICDATAceicdata.comVisit source
- Reference 16NCBIncbi.nlm.nih.govVisit source
- Reference 17GSMAgsma.comVisit source
- Reference 18SATCMsatcm.gov.cnVisit source
- Reference 19WORLDBANKworldbank.orgVisit source
- Reference 20IAEAiaea.orgVisit source
- Reference 21HIMSShimss.orgVisit source
- Reference 22THELANCETthelancet.comVisit source
- Reference 23RSNArsna.orgVisit source
- Reference 24MOEmoe.gov.cnVisit source
- Reference 25PSYpsy.org.cnVisit source
- Reference 26CFScfs.gov.cnVisit source
- Reference 27NATUREnature.comVisit source
- Reference 28SAMRsamr.gov.cnVisit source
- Reference 29IQVIAiqvia.comVisit source
- Reference 30PHARMAINTELpharmaintel.comVisit source
- Reference 31NMPAnmpa.gov.cnVisit source
- Reference 32CFRcfr.orgVisit source
- Reference 33WIPOwipo.intVisit source
- Reference 34GABIONLINEgabionline.netVisit source
- Reference 35ENGLISHenglish.customs.gov.cnVisit source
- Reference 36CLINICALTRIALSclinicaltrials.govVisit source
- Reference 37ROBOTICSSURGERYroboticssurgery.orgVisit source
- Reference 38MOHRSSmohrss.gov.cnVisit source
- Reference 39CIRCcirc.gov.cnVisit source
- Reference 40SWISSREswissre.comVisit source
- Reference 41NHSAnhsa.gov.cnVisit source
- Reference 42MOFmof.gov.cnVisit source